PURSUIT Risk Score Calculator
For NSTEMI (Non-ST-Elevation Myocardial Infarction) Patients
The PURSUIT Risk Score predicts 30-day mortality risk in patients with NSTEMI. Complete the form below to calculate the score and assess patient risk.
PURSUIT Risk Score Result
Interpretation & Clinical Implications
The PURSUIT Risk Score is a clinical tool used to predict the risk of death in patients who have been diagnosed with a specific type of heart attack called NSTEMI (Non-ST-Elevation Myocardial Infarction). Its primary purpose is to help doctors quickly identify high-risk patients who would benefit the most from an early invasive strategy (such as cardiac catheterization and stenting).
The name "PURSUIT" comes from the large clinical trial that developed and validated it: the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy trial.
Detailed Breakdown
1. Clinical Context: NSTEMI
An NSTEMI is a type of heart attack where the coronary artery is partially blocked, not fully occluded. Unlike the more dramatic STEMI (ST-Elevation MI), the ECG changes are more subtle. This creates a spectrum of risk among NSTEMI patients, and the PURSUIT score helps stratify them.
2. Purpose and Utility
The main goals of the PURSUIT Risk Score are:
- Risk Stratification: To separate patients into low, intermediate, and high-risk categories for death.
- Guide Treatment Decisions: To identify which patients should undergo coronary angiography and revascularization (e.g., angioplasty or stenting) within the first 24-72 hours.
- Prognostic Information: To provide patients and families with a more accurate prognosis.
- Standardization: To offer an evidence-based, objective method for assessing risk, reducing subjective variation in care.
3. How the Score is Calculated
The score is calculated at the time of hospital presentation by adding points assigned to seven key clinical variables. A higher total score indicates a higher risk of death.
The variables and their point assignments are as follows:
| Variable | Points Assigned |
|---|---|
| Age | |
| - < 60 years | 0 |
| - 60-69 years | 8 |
| - 70-79 years | 12 |
| - ≥ 80 years | 16 |
| Heart Rate (at enrollment) | |
| - < 70 bpm | 0 |
| - 70-89 bpm | 3 |
| - ≥ 90 bpm | 7 |
| Systolic Blood Pressure (at enrollment) | |
| - < 100 mmHg | 5 |
| - 100-119 mmHg | 3 |
| - ≥ 120 mmHg | 0 |
| Signs of Heart Failure (at enrollment) | |
| - No | 0 |
| - Yes (Rales, Pulmonary Edema) | 6 |
| ST-Segment Depression on ECG | |
| - No | 0 |
| - Yes | 9 |
| Cardiac Enzyme (CK-MB) Elevation | |
| - No | 0 |
| - Yes | 6 |
| Sex | |
| - Male | 0 |
| - Female | 7 |
Total Score Range: 0 to 58
4. Interpretation of the Score
The total score correlates with the predicted 30-day mortality risk. While interpretations can vary slightly, a common classification is:
- Low Risk: Score < 9 (30-day mortality risk ~ 1-2%)
- Intermediate Risk: Score 9 to 18 (30-day mortality risk ~ 3-10%)
- High Risk: Score > 18 (30-day mortality risk can exceed 10-15%)
Clinical Implication: Patients classified as high-risk are strong candidates for an early invasive strategy, as the potential benefit of opening the blocked artery outweighs the risks of the procedure.
Comparison with Other Risk Scores
The PURSUIT score is one of several risk scores for Acute Coronary Syndromes (ACS), which includes NSTEMI and Unstable Angina. Others you may encounter are:
- GRACE Score (Global Registry of Acute Coronary Events): Considered the gold standard and more comprehensive. It predicts both in-hospital and 6-month/post-discharge mortality for all types of ACS (both STEMI and NSTEMI). It is widely recommended in international guidelines.
- TIMI Score (Thrombolysis in Myocardial Infarction): Simpler and easier to calculate, but primarily used for predicting the combined risk of death, re-infarction, or urgent revascularization.
Key Difference: The PURSUIT score is specifically derived from and for NSTEMI patients, while GRACE is more general for all ACS.
Summary
The PURSUIT Risk Score is a validated, practical tool that uses simple, readily available clinical data to predict mortality in NSTEMI patients. By quantifying risk, it empowers clinicians to make more informed, evidence-based decisions about who needs the most aggressive and immediate interventional treatment.
Disclaimer: This information is for educational purposes only. The management of heart attacks is a complex medical process that must be directed by qualified healthcare professionals.
